中飛股份(300489.SZ)完成向子公司安徽中飛實繳出資
格隆匯 8 月 7日丨中飛股份(300489.SZ)公佈,2020年8月6日,公司向安徽中飛繳付第三期第四筆出資款9,700萬元,安徽中飛收到上述款項後,將及時向項目公司履行出資義務。
截至本公告日,公司已完成了對安徽中飛共計5億元(佔安徽中飛註冊資本的100.00%)的實繳出資。
根據對全資子公司的實繳出資計劃,此次提前完成向全資子公司實繳出資事項符合公司的整體戰略考慮,有利於加快推動“紅外光學與激光器件產業化”項目佈局落地,有利於提升公司綜合競爭實力和繼續盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.